Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-30 00:45:25 - browse：2273

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Nonprofit, backed by Microsoft, to certify AI tools in health care

explore

WSS

Russian and Belarusian players banned from a women's tennis tournament in Prague

Does Paxlovid work in people vaccinated against Covid

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Medicare Advantage overpayments discussion gets experts fired up

Stories you might have missed in 2023: health, science, medicine

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

focus

Wikipedia

knowledge

In age of alternative facts, a scholarly course on calling out crap

Merck to acquire Harpoon Therapeutics for $680 million

Peter Hotez and the public health issue of online harassment

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

Medicare details structure of new drug price negotiation program

Hospital chaplains balance Covid safety with patients’ spiritual needs

As demand for Covid shots wanes, Moderna seeks its next success

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Drug repurposing or repositioning? The language matters

American taxpayers paid $1.8 trillion in health care costs in 2022

focus

5 wounded, 2 critically, in Michigan shopping center shooting

FDA early review: GLP

Arena BioWorks launches in Cambridge to speed drug discovery

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

House GOP plan to stem drug shortages differs from Democrats’

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

leisure time

hotspot

explore

focus